Profile
| Metric | Value |
|---|---|
| Full Name | Walgreens Boots Alliance, Inc. |
| Ticker | NASDAQ: WBA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | walgreensbootsalliance.com |
| Employees | 193,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| - | ||
| TTM Dividend Yield | - | |
| PE Ratio | - | |
| Beta | N/A | - |
| Revenue | $148B | |
| Revenue, 1Y Change | +6.17% | |
| EPS | -$10.01 | |
| EPS, 1Y Change | -180.39% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.25 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | WAG | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$10.01 | |
| EPS Estimate | N/A | $1.71 |
| EPS Est. Change | N/A | +117.10% |
| Revenue | $147.66B | |
| Revenue Estimate | N/A | $152.66B |
| Revenue Est. Change | N/A | +3.39% |
| Current Price | - | |
| Price Target | - | $11.45 |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.99 | -$3.57 | -189.47% | |
| $2.85 | -$10.01 | -451.23% | |
| $1.71 | N/A | +117.10% | |
| $1.53 | N/A | +115.27% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $138.46B | $139.08B | +0.45% | |
| $145.52B | $147.66B | +1.47% | |
| $152.66B | N/A | +3.39% | |
| $152.95B | N/A | +3.59% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | - | |
| Price, 3Y | - | |
| - | ||
| - | ||
| Revenue, 1Y | +6.17% | |
| Revenue, 3Y | +11.43% | |
| EPS, 1Y | -180.39% | |
| EPS, 3Y | -441.64% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | - | |
| SMA 200 | N/A | - |
| SMA 200 vs Price | N/A | - |
| SMA 50 | N/A | - |
| SMA 50 vs Price | N/A | - |
| Beta | N/A | - |
| ATR | N/A | - |
| 14-Day RSI | N/A | - |
| 10-Day Volatility | N/A | - |
| 1-Year Volatility | N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.25 | |
| Upcoming | N/A | N/A |
| Dividend Yield | - | |
| Total Dividend | $1.23 | |
| Dividends Paid | $1.26B | |
| Payout Ratio | -8.16% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $147.66B | |
| EPS | -$10.01 | |
| Gross Profit | $24.07B | |
| Gross Margin | 16.30% | |
| Operating Profit | $1.78B | |
| Operating Margin | -82.50% | |
| Net Income | -$15.45B | |
| Net Margin | -10.46% | |
| EBITDA | $4.24B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 3.24 | |
| Current Ratio | 0.68 | |
| Quick Ratio | 0.37 | |
| - | ||
| F-Score | 4 | |
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | - | |
| PB Ratio | - | |
| EV/EBITDA | - | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $10.44B | |
| Cash & Equivalents | $3.11B | |
| Total Assets | $81.04B | |
| Current Assets | $18.34B | |
| Total Liabilities | $68.86B | |
| Current Liabilities | $26.95B | |
| Total Debt | $33.84B | |
| Short Term Debt | $3.96B | |
| Accounts Payable | $14.08B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $156.29B | |
| Operating Expenses | $22.28B | |
| Cost Of Goods Sold | $123.59B | |
| SG&A | $28.11B | |
| D&A | $2.46B | |
| Interest Expense | $0.00 | |
| Income Tax | $1.25B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $1.02B | |
| CFI | $1.88B | |
| CFF | -$538.00M | |
| Capex | $1.38B | |
| Free Cash Flow | -$363.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Deutsche Bank | → | |
| Truist Securities | → | |
| Truist Securities | → | |
| RBC Capital | → | |
| Evercore ISI Group | → | |
| B of A Securities | → | |
| RBC Capital | → | |
| Jefferies | → | |
| TD Cowen | → | |
| UBS | → |
Analyst sentiment
Institutional ownership
Screeners with WBA
Data Sources & References
- WBA Official Website www.walgreensbootsalliance.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1618921/000161892125000056/0001618921-25-000056-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1618921/000161892124000084/0001618921-24-000084-index.htm
- WBA Profile on Yahoo Finance finance.yahoo.com/quote/WBA
- WBA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/wba
FAQ
What is the ticker symbol for Walgreens Boots Alliance, Inc.?
The ticker symbol for Walgreens Boots Alliance, Inc. is NASDAQ:WBA
Does Walgreens Boots Alliance, Inc. pay dividends?
No, Walgreens Boots Alliance, Inc. does not pay dividends
What sector is Walgreens Boots Alliance, Inc. in?
Walgreens Boots Alliance, Inc. is in the Healthcare sector
What industry is Walgreens Boots Alliance, Inc. in?
Walgreens Boots Alliance, Inc. is in the Pharmaceutical Retailers industry
What country is Walgreens Boots Alliance, Inc. based in?
Walgreens Boots Alliance, Inc. is headquartered in United States
When did Walgreens Boots Alliance, Inc. go public?
Walgreens Boots Alliance, Inc. initial public offering (IPO) was on March 17, 1980
Is Walgreens Boots Alliance, Inc. in the S&P 500?
No, Walgreens Boots Alliance, Inc. is not included in the S&P 500 index
Is Walgreens Boots Alliance, Inc. in the NASDAQ 100?
No, Walgreens Boots Alliance, Inc. is not included in the NASDAQ 100 index
Is Walgreens Boots Alliance, Inc. in the Dow Jones?
No, Walgreens Boots Alliance, Inc. is not included in the Dow Jones index
When was Walgreens Boots Alliance, Inc. last earnings report?
Walgreens Boots Alliance, Inc.'s most recent earnings report was on October 14, 2025
When does Walgreens Boots Alliance, Inc. report earnings?
The date for Walgreens Boots Alliance, Inc.'s next earnings report has not been announced yet
